C-J Advisory’s Core Laboratories CLB Stock Holding History

C-J Advisory’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50	Closed	-$2K	–	67
2019 Q3	$2K	Hold	50	–	–	﹤0.01%	164
2019 Q2	$3K	Hold	50	–	–	﹤0.01%	163
2019 Q1	$3K	Hold	50	–	–	﹤0.01%	179
2018 Q4	$3K	Hold	50	–	–	﹤0.01%	147
2018 Q3	$6K	Buy	50 +15	+43%	+$1.69K	﹤0.01%	130
2018 Q2	$4K	Hold	35	–	–	﹤0.01%	151
2018 Q1	$4K	Buy	+35	New	+$3.87K	﹤0.01%	144

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

C-J Advisory's CLB Position: Q4 2019 in Review

C-J Advisory sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 50 shares — an estimated $2K sold.

C-J Advisory first reported a position in CLB in Q1 2018 and held it in 7 quarters. The position peaked at $6K in Q3 2018. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

C-J Advisory reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
C-J Advisory sold 50 Core Laboratories shares in Q4 2019, an estimated $2K.
C-J Advisory first reported a position in Core Laboratories in Q1 2018 and held it in 7 quarters.
C-J Advisory's Core Laboratories position peaked at $6K in Q3 2018.
283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on C-J Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.